Search company, investor...

Antiva Biosciences

Founded Year



Series D | Alive

Total Raised


Last Raised

$31M | 1 yr ago

About Antiva Biosciences

Antiva Biosciences is a biopharmaceutical company developing topical therapeutics for the treatment of diseases caused by HPV infection.

Headquarters Location

6000 Shoreline Court Suite 203

South San Francisco, California, 94080,

United States


Missing: Antiva Biosciences's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Antiva Biosciences's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Antiva Biosciences

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Antiva Biosciences is included in 2 Expert Collections, including Women's Health & Wellness.


Women's Health & Wellness

1,482 items

Startups focused on providing products and services catering to women's health and wellbeing.


Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Latest Antiva Biosciences News

Meet the 4 Winners of World Bank Group and CTA’s Global Women’s HealthTech Awards!

Jan 10, 2022

The World Bank Group and the Consumer Technology Association (CTA) have announced the winners of The Global Women’s HealthTech Awards, recognizing innovative startups that leverage tech to improve women’s health and safety in emerging markets. The winning startups selected by a panel of industry experts are Antiva Biosciences, InnAccel, NIRAMAI, and UE LifeSciences. The Awards attracted over 70 companies from 35 countries, which submitted their innovative…

Antiva Biosciences Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Antiva Biosciences Rank

Antiva Biosciences Frequently Asked Questions (FAQ)

  • When was Antiva Biosciences founded?

    Antiva Biosciences was founded in 2012.

  • Where is Antiva Biosciences's headquarters?

    Antiva Biosciences's headquarters is located at 6000 Shoreline Court, South San Francisco.

  • What is Antiva Biosciences's latest funding round?

    Antiva Biosciences's latest funding round is Series D.

  • How much did Antiva Biosciences raise?

    Antiva Biosciences raised a total of $87.97M.

  • Who are the investors of Antiva Biosciences?

    Investors of Antiva Biosciences include Sofinnova Ventures, Canaan Partners, Brace Pharma Capital, Osage University Partners, Lumira Ventures and 14 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.